RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Hyperparathyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Sep 2011 - 61 pages - $2,000
Hyperparathyroidism - Pipeline Review, Q1 2011
Mar 2011 - 35 pages - $500
Hyperparathyroidism - Pipeline Review, H2 2011
Oct 2011 - 49 pages - $500
Hyperparathyroidism Global Clinical Trials Review, Q2, 2011
Jun 2011 - 61 pages - $1,000
Hyperparathyroidism Global Clinical Trials Review, H2, 2011
Aug 2011 - 88 pages - $1,000
Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report
Aug 2008 - 117 pages - $2,350
MarketWatch: Biotechnology
Dec 2008 - 35 pages - $200
Osteoporosis & Bone Metabolism Disorders: World Market 2010-2025
Apr 2010 - 121 pages - $2,350
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Metabolism del
Hyperparathyroidism del
Development phase
Preregistration del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Nanotechnology
Other
Research supplies
Stem cells

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us